ArticleUrology case reports2026
Renal sclerosing AML/PEComa in a male - A case report and literature review.
Article in Urology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sclerosing angiomyolipomas (AMLs) are a subtype of perivascular epithelioid cell-omas (PEComas) with significant stromal hyalinisation and AML-like features. Immunochemically, they show myomelanocytic differentiation. Sclerosing AMLs/PEComas are predominantly retroperitoneal, follow a benign course, and are overwhelmingly reported in females. Here we report a renal sclerosing AML/PEComa in a male. This case highlights the importance of considering sclerosing AMLs/PEComas as a likely indolent differential for small renal masses in men, as accepted knowledge of small renal masses with these characteristics suggests 70-80 % will be malignant.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.